id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1444-0037,FDA,FDA-2013-D-1444,"Final Guidance; Pharmacy Compounding of Human Drug
Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Availability",Notice,Notice of Availability,2014-07-02T04:00:00Z,2014,7,2014-07-02T04:00:00Z,,2014-07-03T13:06:52Z,2014-15372,0,0,09000064817870fb
FDA-2013-D-1444-0038,FDA,FDA-2013-D-1444,"Final Guidance; Pharmacy Compounding of Human Drug
Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act",Other,Guidance,2014-07-02T04:00:00Z,2014,7,2014-07-02T04:00:00Z,,2024-11-12T05:26:14Z,,1,0,090000648178769a
FDA-2013-D-1444-0001,FDA,FDA-2013-D-1444,"Draft Guidance; Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Withdrawal of Guidances",Notice,Notice of Availability,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,2014-02-04T04:59:59Z,2014-02-05T02:03:21Z,2013-28963,0,0,09000064814a6225
FDA-2013-D-1444-0002,FDA,FDA-2013-D-1444,"Guidance Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act",Other,Guidance,2013-12-04T05:00:00Z,2013,12,2013-12-04T05:00:00Z,2013-02-04T04:59:59Z,2019-10-23T13:47:04Z,,0,0,09000064814a6790